Satsuma Pharmaceuticals (STSA) Acquired by SNBL
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stock futures fall as fading Iran peace prospects drive up oil, yields
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
SNBL to Acquire Satsuma Pharmaceuticals
April 16, 2023 7:41 PM EDTTransaction delivers immediate value and liquidity to Satsuma stockholders
SNBL to acquire all outstanding shares of Satsuma for upfront cash consideration of $0.91 per share
Satsuma stockholders to also receive non-tradeable CVR of up to $5.77 per share
With the goal of maximizing value for stockholders, Satsumas Board has carefully considered strategic options for Satsuma and STS101 and fully supports this transaction with SNBL
SOUTH SAN FRANCISCO, Calif., April 16, 2023 (GLOBE NEWSWIRE) --... More
